Literature DB >> 29961137

Public reporting on cardiac electrophysiology procedures and outcomes: where are we now and where are we headed?

Samuel M Kim1, Jim W Cheung2.   

Abstract

Over the years, public reporting of patient outcomes has been promoted as a means to improve healthcare quality. More recently, in response to dramatic rises in healthcare costs, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 was implemented in an effort to link quality with reimbursement. As part of a value-based model, public reporting of procedural outcomes has been incorporated into this initiative. Outcomes measures that have been introduced in cardiology include heart failure readmission and post-myocardial infarction medication prescription. Public reporting of these data has led not only to positive changes but also to unintended negative consequences. The limited number of existing registries and lack of clear consensus on quality metrics have posed challenges for quality and value assessment in cardiac electrophysiology. After learning from the lessons of existing models of public reporting, physicians, professional societies, stakeholders, and patients will need to collaborate to develop a health care model that can improve outcomes and reduce waste.

Entities:  

Keywords:  Electrophysiology; Outcome and performance measures; Public reporting

Mesh:

Year:  2018        PMID: 29961137     DOI: 10.1007/s10840-018-0400-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  32 in total

Review 1.  Prevalence and Data Transparency of National Clinical Registries in the United States.

Authors:  Heather Lyu; Michol Cooper; Kavita Patel; Michael Daniel; Martin A Makary
Journal:  J Healthc Qual       Date:  2016 Jul-Aug       Impact factor: 1.095

2.  Examining the role of patient experience surveys in measuring health care quality.

Authors:  Rebecca Anhang Price; Marc N Elliott; Alan M Zaslavsky; Ron D Hays; William G Lehrman; Lise Rybowski; Susan Edgman-Levitan; Paul D Cleary
Journal:  Med Care Res Rev       Date:  2014-07-15       Impact factor: 3.929

3.  The Medicare Access And CHIP Reauthorization Act: Effects On Medicare Payment Policy And Spending.

Authors:  Peter S Hussey; Jodi L Liu; Chapin White
Journal:  Health Aff (Millwood)       Date:  2017-04-01       Impact factor: 6.301

Review 4.  Public reporting of PCI outcomes: for better or for worse.

Authors:  Brian J Potter; Robert W Yeh; Duane S Pinto
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

5.  Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.

Authors:  Daniel J Friedman; Craig S Parzynski; Paul D Varosy; Jordan M Prutkin; Kristen K Patton; Ali Mithani; Andrea M Russo; Jeptha P Curtis; Sana M Al-Khatib
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

6.  National spending on cardiovascular disease, 1996-2008.

Authors:  George Miller; Paul Hughes-Cromwick; Charles Roehrig
Journal:  J Am Coll Cardiol       Date:  2011-11-01       Impact factor: 24.094

7.  The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider.

Authors:  Gregg C Fonarow; Marvin A Konstam; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2017-10-10       Impact factor: 24.094

8.  Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.

Authors:  Sean D Pokorney; Amy L Miller; Anita Y Chen; Laine Thomas; Gregg C Fonarow; James A de Lemos; Sana M Al-Khatib; Eric D Peterson; Tracy Y Wang
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

9.  Medical records and quality of care in acute coronary syndromes: results from CRUSADE.

Authors:  Shannon M Dunlay; Karen P Alexander; Chiara Melloni; Jennifer L Kraschnewski; Li Liang; W Brian Gibler; Matthew T Roe; E Magnus Ohman; Eric D Peterson
Journal:  Arch Intern Med       Date:  2008-08-11

10.  Scorecard cardiovascular medicine. Its impact and future directions.

Authors:  E J Topol; R M Califf
Journal:  Ann Intern Med       Date:  1994-01-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.